Team Science Day 2024
Esteemed partners from around the country joined us on the frontier of biomedical science during Team Science Day on Sept. 16 in New York City. This event convened leaders across the public and private sectors, academia, and patient advocacy groups to explore what it will take to achieve tomorrow’s breakthroughs.
Photos Credit: @seancheesecake / https://www.cheesean.com/
Sponsors, panelists, and attendees are invited to help us keep the conversation going with the Team Science Day Social Toolkit.
Session Recordings
Building Bridges to Breakthroughs
Julie Gerberding, President and Chief Executive Officer, FNIH
View Session
Fireside Chat
Diana Bianchi, Director, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Julie Gerberding, President and Chief Executive Officer, FNIH
Walter Koroshetz, Director, National Institute of Neurological Disorders and Stroke (NINDS)
Joni Rutter, Director, National Center for Advancing Translational Sciences (NCATS)
Accelerating Medicines Partnership® for ALS
Joseph P. Menetski (moderator), Senior Vice President, Chief Translational Science Officer, FNIH
Stephanie Fradette, Vice President, Head of Neuromuscular Development Unit, Biogen
Walter Koroshetz, Director, National Institute of Neurological Disorders and Stroke (NINDS)
Dave Shulman, Patient Advocate
Alessio Travaglia, Director, Neuroscience, FNIH
How AI is Transforming Healthcare
Jim Weiss (moderator), Chairman and Founder, Real Chemistry
Brian Anderson, Chief Executive Officer and Co-Founder, Coalition for Healthcare AI (CHAI)
Luca Foschini, President and Chief Executive Officer, Sage Bionetworks
Jessica Liao, Principal Product Manager, Microsoft
Clinical Trial Innovation at Scale
Monica Bertagnolli, Director, National Institutes of Health (NIH), live via webcast
Julie Gerberding, President and Chief Executive Officer, FNIH
Hilary Marston, Chief Medical Officer, Food and Drug Administration (FDA)
The Future of Health in the Era of Obesity Treatments
Nina Kjellson (moderator), General Partner, Canaan Partners
Javed Butler, Senior Vice President, Baylor Scott and White Health (BSWH)
Joe Nadglowski, President and Chief Executive Officer, Obesity Action Coalition
Mark Pruzanski, Former CEO, Versanis Bio
Melissa Thomas, Vice President, Diabetes, Obesity, and Cardiometabolic Research, Lilly Research Laboratories
Precision Oncology: From Treatment to Cure
Stacey Adam (moderator), Vice President, Science Partnerships, Translational Science, FNIH
Irene Ghobrial, Senior Vice President for Experimental Medicine, Professor of Medicine, Dana-Farber Cancer Institute
Roy Herbst, Professor of Medicine, Chief of Medical Oncology, Yale School of Medicine
Rochelle Prosser, Founder, Orchid Healthcare Solutions
Karen Reckamp, Professor in Medicine, Director of the Division of Medical Oncology, Cedars Sinai
Celebrating Scientists as Stars
Gilbert S. Omenn (moderator), Harold T. Shapiro Distinguished University Professor, University of Michigan, Board of Directors, FNIH
Christopher Bartley, Chief, Translational Immunopsychiatry Unit, National Institute of Mental Health; 2021 Deeda Blair Research Initiative Award Recipient
Nikhil Wagle, Vice President and Global Head of Translational Medicine at Genentech; 2022 Trailblazer Prize for Clinician-Scientists Award Recipient
Decoding Depression: Predicting Outcomes in Mental Health
Joseph P. Menetski (moderator), Senior Vice President, Chief Translational Science Officer, FNIH
Amit Etkin, Chief Executive Officer and Founder, Alto Neuroscience
Katherine Burdick, Associate Vice Chair for Research, Department of Psychiatry, Brigham and Women’s Hospital
Conor Liston, Professor of Psychiatry, Weill Cornell Medical College
Brian Michel, Associate VP of Foundations and Government Relations, Mental Health America
Lynne Zydowsky, Chief Science Officer, Alexandria Real Estate Equities, Inc.
New Models for Rare Disease Drug Development
Courtney Silverthorn (moderator), Vice President, Strategic Alliances and Innovation, FNIH
Joni Rutter, Director, National Center for Advancing Translational Sciences (NCATS)
Iwona Jeske DuPont, Vice President, Rare Disease, Pfizer
Hilary Marston, Chief Medical Officer, Food and Drug Administration (FDA)
Edward Neilan, Chief Medical and Scientific Officer, National Organization for Rare Disorders
A Transformative Time for Women's Health
Michael Santos, Senior Vice President, Chief Population Health Science Officer, FNIH
Diana Bianchi, Director, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Ru-fong Joanne Cheng, Director, Women’s Health Innovations, Bill & Melinda Gates Foundation
Jessica Federer, Independent Board Member
Kima Tozay, Patient Advocate
Team Science Day is made possible through the generosity of our sponsors:
